NAD+ Research: Cofactor Biology vs Direct Administration Claims

A central redox cofactor

NAD+ accepts and donates electrons through the NAD+/NADH couple, supporting glycolysis, mitochondrial respiration, and many biosynthetic reactions. It is also consumed by sirtuins, PARPs, and CD38-related enzymes.

Cellular levels are tightly regulated

Cells synthesize and recycle NAD+ through multiple pathways. Tissue concentrations, subcellular compartments, age, inflammation, and metabolic state all influence the pool.

Precursor evidence is not direct-NAD evidence

Studies of nicotinamide riboside, nicotinamide mononucleotide, niacin, or nicotinamide evaluate different molecules with different absorption and metabolism. Those results cannot automatically support direct NAD+ administration.

Route and stability matter

NAD+ is chemically sensitive and may be degraded extracellularly. Oral, parenteral, and cellular-exposure studies answer different questions. Product oxidation state, purity, degradation, and delivery strongly influence interpretation.

Clinical claims exceed the evidence

Direct-administration studies are limited, and broad claims involving energy, cognition, aging, or recovery are not established by NAD+'s essential biochemical role alone.

This article is provided for scientific and educational purposes. It does not describe or recommend human or veterinary use. Research findings may be limited by study design, model selection, material identity, sample size, or lack of independent replication.